ALBERT P HIRDT
- Type
- Physician · Allopathic & Osteopathic Physicians / Allergy & Immunology
- Where
- NEW PALTZ, NY
- NPI
- 1396792636
- Received
- $35,970 in 153 records, 2019 to 2025 ($10,376 general, $25,594 research)
- As principal investigator
- $25,685 of research payments to others in 8 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 1 | $27 |
| 2024 | General payment | 8 | $256 |
| 2023 | General payment | 55 | $4,623 |
| 2023 | Research payment | 3 | $19,260 |
| 2022 | General payment | 39 | $3,295 |
| 2022 | Research payment | 1 | $3,611 |
| 2021 | General payment | 30 | $645 |
| 2021 | Research payment | 1 | $1,166 |
| 2020 | General payment | 6 | $1,397 |
| 2019 | General payment | 8 | $130 |
| 2019 | Research payment | 1 | $1,557 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Blueprint Medicines Corporation | 24 | $30,902 | 2020–2024 |
| AstraZeneca Pharmaceuticals LP | 14 | $2,900 | 2019–2023 |
| GlaxoSmithKline, LLC. | 41 | $537 | 2021–2023 |
| GENZYME CORPORATION | 22 | $421 | 2021–2025 |
| Genentech USA, Inc. | 16 | $376 | 2019–2023 |
| BioCryst US Sales Co., LLC | 11 | $312 | 2021–2024 |
| Regeneron Healthcare Solutions, Inc. | 11 | $252 | 2019–2024 |
| Grifols USA, LLC | 3 | $63 | 2019–2021 |
| Novartis Pharmaceuticals Corporation | 3 | $49 | 2019–2023 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 | 2021 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 | 2021 |
| kaleo, Inc. | 1 | $22 | 2021 |
| LEO Pharma Inc. | 1 | $21 | 2022 |
| CSL Behring | 1 | $21 | 2023 |
| Amgen Inc. | 1 | $19 | 2022 |
| Currax Pharmaceuticals LLC | 1 | $14 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 6 | $25,594 |
| Honoraria | 6 | $6,438 |
| Food and Beverage | 137 | $2,694 |
| Travel and Lodging | 4 | $1,243 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-03-27 | GENZYME CORPORATION | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2024-12-18 | BioCryst US Sales Co., LLC | $22 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2024 | |
| 2024-10-16 | Blueprint Medicines Corporation | $132 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2024 | |
| 2024-09-12 | Blueprint Medicines Corporation | $9 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2024 | |
| 2024-08-08 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-06-21 | Regeneron Healthcare Solutions, Inc. | $15 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-02-28 | BioCryst US Sales Co., LLC | $21 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2024 | |
| 2024-01-17 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-01-08 | BioCryst US Sales Co., LLC | $21 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2024 | |
| 2023-12-12 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-12-08 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-12-07 | GENZYME CORPORATION | $10 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-11-16 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-11-09 | GlaxoSmithKline, LLC. | $4 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-10-31 | GlaxoSmithKline, LLC. | $5 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-10-31 | GlaxoSmithKline, LLC. | $4 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-10-26 | Blueprint Medicines Corporation | $1,872 | Research payment | Cash or cash equivalent | Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients With Evidence of Systemic Mast | 2023 | |
| 2023-10-26 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-10-19 | GlaxoSmithKline, LLC. | $7 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-10-17 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-10-04 | GENZYME CORPORATION | $9 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-10-02 | Blueprint Medicines Corporation | $2,088 | Honoraria | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-10-02 | Blueprint Medicines Corporation | $522 | Honoraria | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-10-02 | Blueprint Medicines Corporation | $86 | Travel and Lodging | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-09-28 | GlaxoSmithKline, LLC. | $3 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-09-21 | GlaxoSmithKline, LLC. | $5 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-09-07 | Blueprint Medicines Corporation | $16 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-09-07 | GlaxoSmithKline, LLC. | $4 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-09-06 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-09-01 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-08-19 | Blueprint Medicines Corporation | $49 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-19 | Blueprint Medicines Corporation | $29 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-19 | Blueprint Medicines Corporation | $24 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-19 | Blueprint Medicines Corporation | $14 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-19 | Blueprint Medicines Corporation | $14 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-18 | Blueprint Medicines Corporation | $585 | Travel and Lodging | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-17 | Blueprint Medicines Corporation | $536 | Travel and Lodging | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-17 | Blueprint Medicines Corporation | $35 | Travel and Lodging | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-08-17 | GlaxoSmithKline, LLC. | $2 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-08-10 | GlaxoSmithKline, LLC. | $8 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-07-27 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-07-26 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-07-20 | Blueprint Medicines Corporation | $12,037 | Research payment | Cash or cash equivalent | Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients With Evidence of Systemic Mast | 2023 | |
| 2023-07-13 | GlaxoSmithKline, LLC. | $9 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-06-22 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-06-20 | Blueprint Medicines Corporation | $20 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-06-13 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-06-08 | Regeneron Healthcare Solutions, Inc. | $29 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-05-15 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-05-09 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-04-27 | GENZYME CORPORATION | $9 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-04-20 | GlaxoSmithKline, LLC. | $8 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-03-29 | Blueprint Medicines Corporation | $5,350 | Research payment | Cash or cash equivalent | Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients With Evidence of Systemic Mast | 2023 | |
| 2023-03-23 | GENZYME CORPORATION | $29 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-03-23 | CSL Behring | $21 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2023 | |
| 2023-03-21 | BioCryst US Sales Co., LLC | $32 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2023 | |
| 2023-03-13 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-03-08 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2023 | |
| 2023-03-07 | GlaxoSmithKline, LLC. | $5 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-02-09 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | XOLAIR Drug, Pulmonary/Respiratory Diseases | 2023 | |
| 2023-02-07 | GlaxoSmithKline, LLC. | $7 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-02-07 | GlaxoSmithKline, LLC. | $4 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-01-31 | GlaxoSmithKline, LLC. | $25 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-01-31 | GENZYME CORPORATION | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-01-17 | Genentech USA, Inc. | $26 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2023 | |
| 2023-01-10 | GlaxoSmithKline, LLC. | $31 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2023-01-03 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2023 | |
| 2022-12-06 | Genentech USA, Inc. | $21 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2022-11-25 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2022 | |
| 2022-11-22 | Regeneron Healthcare Solutions, Inc. | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-11-10 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2022-11-03 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-10-26 | Blueprint Medicines Corporation | $696 | Honoraria | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2022 | |
| 2022-10-20 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-10-18 | LEO Pharma Inc. | $21 | Food and Beverage | In-kind items and services | ADBRY Biological, DERMATOLOGY | 2022 | |
| 2022-10-06 | BioCryst US Sales Co., LLC | $34 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2022 | |
| 2022-09-29 | Genentech USA, Inc. | $29 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2022-09-28 | GENZYME CORPORATION | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-09-23 | Blueprint Medicines Corporation | $1,305 | Honoraria | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2022 | |
| 2022-09-22 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-08-30 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-08-25 | Blueprint Medicines Corporation | $36 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2022 | |
| 2022-08-18 | GlaxoSmithKline, LLC. | $9 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-08-16 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2022-08-11 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2022 | |
| 2022-08-04 | Blueprint Medicines Corporation | $3,611 | Research payment | Cash or cash equivalent | Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients With Evidence of Systemic Mast | 2022 | |
| 2022-08-04 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-08-02 | Regeneron Healthcare Solutions, Inc. | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-07-28 | GlaxoSmithKline, LLC. | $27 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-07-26 | Genentech USA, Inc. | $26 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2022-07-19 | BioCryst US Sales Co., LLC | $30 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2022 | |
| 2022-06-30 | Genentech USA, Inc. | $28 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-06-09 | Regeneron Healthcare Solutions, Inc. | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2022 | |
| 2022-05-26 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-05-19 | GENZYME CORPORATION | $21 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-05-11 | Blueprint Medicines Corporation | $522 | Honoraria | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2022 | |
| 2022-05-11 | Genentech USA, Inc. | $26 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2022-05-03 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2022 | |
| 2022-04-14 | GlaxoSmithKline, LLC. | $6 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-03-17 | GlaxoSmithKline, LLC. | $5 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-02-17 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-02-15 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-02-10 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2022 | |
| 2022-01-28 | BioCryst US Sales Co., LLC | $23 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2022 | |
| 2022-01-20 | GENZYME CORPORATION | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2022 | |
| 2022-01-20 | GlaxoSmithKline, LLC. | $5 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2022 | |
| 2022-01-11 | Genentech USA, Inc. | $19 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2022 | |
| 2021-12-16 | GlaxoSmithKline, LLC. | $31 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2021 | |
| 2021-12-14 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2021 | |
| 2021-12-09 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-12-07 | Currax Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2021 | |
| 2021-11-23 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-11-03 | AstraZeneca Pharmaceuticals LP | $1,166 | Research payment | Cash or cash equivalent | FASENRA Biological, Respiratory | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2021 |
| 2021-11-03 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-09-30 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-09-16 | BioCryst US Sales Co., LLC | $25 | Food and Beverage | In-kind items and services | Orladeyo Drug, Immunology | 2021 | |
| 2021-09-01 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2021 | |
| 2021-08-24 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-08-23 | Genentech USA, Inc. | $18 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2021 | |
| 2021-08-12 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-08-03 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | CINQAIR Biological, Respiratory | 2021 | |
| 2021-07-28 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2021 | |
| 2021-07-22 | GENZYME CORPORATION | $16 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-07-14 | BioCryst US Sales Co., LLC | $24 | Food and Beverage | In-kind items and services | Orladeyo Drug, Immunology | 2021 | |
| 2021-06-30 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2021 | |
| 2021-06-15 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-06-08 | Genentech USA, Inc. | $20 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2021 | |
| 2021-05-19 | GENZYME CORPORATION | $21 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2021 | |
| 2021-05-11 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | CINQAIR Biological, Respiratory | 2021 | |
| 2021-04-27 | BioCryst US Sales Co., LLC | $32 | Food and Beverage | In-kind items and services | Orladeyo Drug, Immunology | 2021 | |
| 2021-04-21 | Genentech USA, Inc. | $21 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2021 | |
| 2021-04-06 | Regeneron Healthcare Solutions, Inc. | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2021 | |
| 2021-03-24 | kaleo, Inc. | $22 | Food and Beverage | In-kind items and services | AUVI-Q Drug, ALLERGY | 2021 | |
| 2021-03-09 | Grifols USA, LLC | $24 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2021 | |
| 2021-02-17 | BioCryst US Sales Co., LLC | $43 | Food and Beverage | In-kind items and services | Orladeyo Drug, Immunology | 2021 | |
| 2021-01-22 | Takeda Pharmaceuticals U.S.A., Inc. | $26 | Food and Beverage | In-kind items and services | MOTEGRITY Drug, INTERNAL MEDICINE | 2021 | |
| 2021-01-19 | Regeneron Healthcare Solutions, Inc. | $27 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2021 | |
| 2021-01-06 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2021 | |
| 2020-10-15 | AstraZeneca Pharmaceuticals LP | $11 | Food and Beverage | In-kind items and services | FASENRA Drug, Respiratory | 2020 | |
| 2020-10-14 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2020 | |
| 2020-08-19 | Blueprint Medicines Corporation | $1,305 | Honoraria | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2020 | |
| 2020-08-01 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2020 | |
| 2020-06-11 | Grifols USA, LLC | $21 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2020 | |
| 2020-01-30 | Regeneron Healthcare Solutions, Inc. | $14 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2020 | |
| 2019-11-21 | Regeneron Healthcare Solutions, Inc. | $20 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-11-14 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | XOLAIR Biological, RESPIRATORY | 2019 | |
| 2019-11-13 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FASENRA Drug, Respiratory | 2019 | |
| 2019-10-24 | Genentech USA, Inc. | $20 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2019 | |
| 2019-08-29 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FASENRA Drug, Respiratory | 2019 | |
| 2019-08-13 | Grifols USA, LLC | $17 | Food and Beverage | In-kind items and services | Gamunex-C Biological, Immunology and Neurology | 2019 | |
| 2019-08-01 | AstraZeneca Pharmaceuticals LP | $11 | Food and Beverage | In-kind items and services | FASENRA Drug, Respiratory | 2019 | |
| 2019-05-31 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | XOLAIR Biological, RESPIRATORY | 2019 | |
| 2019-01-24 | AstraZeneca Pharmaceuticals LP | $1,557 | Research payment | Cash or cash equivalent | FASENRA Drug, Respiratory | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-10 | AstraZeneca Pharmaceuticals LP | HIRDT, ALBERT P, OFFICE | $4,501 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2025 |
| 2022-10-17 | AstraZeneca Pharmaceuticals LP | DR ALBERT P HIRDT | $233 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2022 |
| 2022-05-19 | Blueprint Medicines Corporation | ALBERT P HIRDT DOPC | $1,203 | Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients With Evidence of Systemic Mast | 2022 |
| 2022-03-07 | AstraZeneca Pharmaceuticals LP | HIRDT, ALBERT P, OFFICE | $2,798 | The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do no | 2022 |
| 2021-08-05 | AstraZeneca Pharmaceuticals LP | HIRDT, ALBERT P, OFFICE | $1,166 | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2021 |
| 2021-02-01 | AstraZeneca Pharmaceuticals LP | DR ALBERT P HIRDT | $4,430 | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2021 |
| 2020-02-06 | AstraZeneca Pharmaceuticals LP | HIRDT, ALBERT P, OFFICE | $5,597 | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2020 |
| 2019-05-02 | AstraZeneca Pharmaceuticals LP | Albert P Hirdt Do Pc | $5,755 | The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do no | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In New Paltz, NY, county Ulster County, NY, state New York; placed by its city name.
| Measure | Place (city or town) New Paltz, NY | County Ulster County, NY | State New York |
|---|---|---|---|
| Population B01003 | 8,314 | 182,601 | 19,852,366 |
| Population, 2020 census P1 | 7,324 | 181,851 | 20,201,249 |
| Median age B01002 | 21.5 | 44.1 | 39.8 |
| Under 18 B01001 | 8.6% | 17.1% | 20.5% |
| 65 and over B01001 | 7.7% | 21.3% | 17.9% |
| Households B11001 | 2,538 | 74,278 | 7,722,646 |
| Foreign born B05002 | 9.7% | 8.1% | 22.8% |
| Median household income B19013 | $52,774 | $86,271 | $85,974 |
| Median family income B19113 | $90,976 | $113,659 | $106,873 |
| Per capita income B19301 | $22,485 | $47,778 | $50,712 |
| Poverty rate B17001 | 38.2% | 14.6% | 14.0% |
| Unemployment rate B23025 | 10.7% | 5.4% | 6.4% |
| Civilian labor force B23025 | 3,748 | 90,274 | 10,171,766 |
| Mean commute (minutes) B08013 | 21.4 | 27.5 | 32.6 |
| Bachelor's degree or higher B15003 | 73.3% | 38.2% | 40.2% |
| Housing units B25001 | 2,620 | 86,503 | 8,585,241 |
| Owner-occupied B25003 | 20.3% | 69.9% | 54.3% |
| Renters B25003 | 79.7% | 30.1% | 45.7% |
| Median home value B25077 | $414,500 | $352,500 | $423,800 |
| Median gross rent B25064 | $1,672 | $1,425 | $1,621 |
| White, not Hispanic B03002 | 63.5% | 72.4% | 52.8% |
| Black B03002 | 7.0% | 5.7% | 13.4% |
| Hispanic or Latino B03002 | 15.0% | 12.2% | 19.8% |
| Asian B03002 | 5.7% | 2.1% | 9.0% |
| American Indian and Alaska Native B03002 | 0.1% | 0.0% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New Paltz, NY.
Comments